Skip to main content
Clinical Trials/NCT07427485
NCT07427485
Active, not recruiting
Not Applicable

Cognitive Rehabilitation With Immersive Virtual Reality (IVR) in Schizophrenia: a Pilot Randomized Waiting List Controlled Feasibility Study

Azienda Sanitaria Locale Napoli 3 Sud, UOCSM Torre del Greco1 site in 1 country40 target enrollmentStarted: March 11, 2025Last updated:

Overview

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Azienda Sanitaria Locale Napoli 3 Sud, UOCSM Torre del Greco
Enrollment
40
Locations
1
Primary Endpoint
Positive and Negative Syndrome Scale (PANSS)

Overview

Brief Summary

Virtual reality-based rehabilitation has recently gained increasing attention in the field of cognitive rehabilitation, allowing patients to engage in simulated real-life scenarios within a safe and controlled setting. The feasibility and safety of immersive VR-based cognitive rehabilitation in individuals with schizophrenia is currently insufficiently explored. This study seeks to evaluate whether immersive immersive virtual reality-based rehabilitation can be safely and practically implemented in a community psychiatric setting. The study also aims to explore preliminary effects on negative symptoms, cognitive performance, and global functioning compared with treatment as usual in a waiting-list control group.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 67 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Individuals with Schizophrenia/Schizoaffective Disorder (DSM-5-TR)
  • Age 18-67 years
  • Chronic phase of illness
  • Able to provide a valid informed consent

Exclusion Criteria

  • Recent substance use (less than six months)
  • Concomitant intellectual disability or neurological disorders (e.g., neurodegenerative disorders, Parkison's disease, brain cancer) that may impair the ability to undergo cognitive rehabilitation
  • With a recent (less than six weeks from the enrolling date) symptom exacerbation, hospitalization or change in pharmacotherapy
  • Acute phase of illness

Arms & Interventions

Immersive Virtual Reality-Based Cognitive Rehabilitation

Experimental

patients will undergo IVR-based cognitive rehabilitation sessions (about 45minutes) for 12 weeks as an adjunct to the Therapy as Usual (TAU)

Intervention: CEREBRUM VR (Device)

Waiting List

Other

The patients randomized to the waiting list arm will not undergo IVR rehabilitation, but rather continue with TAU

Intervention: Waiting List (Other)

Outcomes

Primary Outcomes

Positive and Negative Syndrome Scale (PANSS)

Time Frame: From enrollment to the end of treatment at 12 weeks

Total score, positive and negative symptoms, general psychopathology

Secondary Outcomes

  • Global Assessment of Functioning (GAF)(From enrollment to the end of treatment at 12 weeks)
  • Digital Symbol Substitution Test (DSST)(From enrollment to the end of treatment at 12 weeks)
  • Animal Naming Test (ANT)(From enrollment to the end of treatment at 12 weeks)
  • Trial Making Test - A (TMT)(From enrollment to the end of treatment at 12 weeks)
  • Simple Reaction Time (SRT)(From enrollment to the end of treatment at 12 weeks)
  • Choice Reaction Time (CRT)(From enrollment to the end of treatment at 12 weeks)

Investigators

Sponsor
Azienda Sanitaria Locale Napoli 3 Sud, UOCSM Torre del Greco
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials